Brief: Dr Reddy's Got Marketing Authorization For Generic Semaglutide Tablets In India From Dcgi
May 12 (Reuters) - Dr Reddy's Laboratories Ltd REDY.NS: GOT MARKETING AUTHORIZATION FOR GENERIC SEMAGLUTIDE TABLETS IN INDIA FROM DCGI Source text: [ID:] Further company coverage: REDY.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption